Fig. 5
From: A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario
![Fig. 5](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12967-016-1073-8/MediaObjects/12967_2016_1073_Fig5_HTML.gif)
Positron emission tomography (PET) study of MRD. a A20 tumor-bearing mouse at day 25 p.t.i. (pre-CHOP treatment). Primary tumor FDG uptake is observed. Volumes of interest (VOI) are shown with circles: primary tumor (blue) and muscle (skyblue). T/NT: 4.5. b Animal with complete tumor remission at day 45 p.t.i. (post-CHOP treatment). FDG uptake is below detection level in primary tumor or in any organs. c Animal without tumor remission at day 45 p.t.i. (post-CHOP treatment). Primary tumor and hepatic metastasis are observed. VOIs are shown with circles: primary tumor (blue), hepatic metastasis (red) and muscle (sky-blue). T/NT: 4.0, liver/muscle ratio: 3.3. 1 axial section; 2 saggital section, and 3 coronal section